StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Trifluoroacetic acid → Methyl 3-benzyloxy-7-ethoxycarbonyl-4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate

HRID 1453838
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1453838
[CH2:1]([O:8][C:9]1[C:10]([C:33]([O:35][CH3:36])=[O:34])=[N:11][N:12]([CH:18]([C:28]([O:30][CH2:31][CH3:32])=[O:29])[CH2:19][NH:20][C:21]([O:23]C(C)(C)C)=O)[C:13]=1C(OC)=O)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C(O)(C(F)(F)F)=O>C(Cl)(Cl)Cl.CCOC(C)=O>[CH2:1]([O:8][C:9]1[C:10]([C:33]([O:35][CH3:36])=[O:34])=[N:11][N:12]2[CH:18]([C:28]([O:30][CH2:31][CH3:32])=[O:29])[CH2:19][NH:20][C:21](=[O:23])[C:13]=12)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

5

Edukt 2

HCID 6422Trifluoroacetic acidHCID 68952340Dimethyl 4-benzyloxy-1-{2-[(tert-butoxycarbonyl)amino]-1-(ethoxycarbonyl)ethyl}-1H-pyrazole-3,5-dicarboxylate

Produkt 1

HCID 57528488Methyl 3-benzyloxy-7-ethoxycarbonyl-4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6212ChloroformLösungsmittel
HCID 8857
Ethyl Acetate
Lösungsmittel

Versuchsvorschrift

To a solution of dimethyl 4-(benzyloxy)-1-{2-[(tert-butoxycarbonyl)amino]-1-(ethoxycarbonyl)ethyl}-1H-pyrazole-3,5-dicarboxylate (6.97 g, 13.78 mmol) in CHCl3 (150 mL) was added TFA (30 mL). The reaction was allowed to stir at room temperature overnight. The solvent was removed in vacuo, and the residue was partitioned between saturated aqueous NaHCO3 solution and CHCl3. The aqueous layer was extracted three times with CHCl3, and the combined organic extracts were dried over Na2SO4. Concentration in vacuo afforded a yellow oil which was dissolved in EtOAc (30 mL) and sonicated. The resulting precipitate was collected by filtration to afford the title product as a white solid. The filtrate was further purified by reverse phase chromatography on a C-18 column using a gradient elution of 95-5% H2O (0.1% TFA)/CH3CN (0.1% TFA), and collection and concentration of the appropriate fractions afforded additional title product as a white solid. 1H NMR (400 MHz, d6-DMSO) δ 8.38 (d, J=5.2 Hz, 1H), 6.45-7.43 (m, 2H), 7.38-7.30 (m, 3H), 5.55 (d, J=4.0 Hz, 1H), 5.26 (dd, J=11.2, 40.0 Hz, 2H), 4.23-4.14 (m, 2H), 3.97 (dd, J=5.0, 13.8 Hz, 1H), 3.79 (s, 3H), 3.71 (dd, J=5.4, 13.8 Hz, 1H), 1.18 (t, J=7.0 Hz, 3H); ES MS (M+H)=374.

Aufarbeitung

  1. customThe solvent was removed in vacuo
  2. customthe residue was partitioned between saturated aqueous NaHCO3 solution and CHCl3
  3. extractionThe aqueous layer was extracted three times with CHCl3
  4. dry with materialthe combined organic extracts were dried over Na2SO4
  5. concentrationConcentration in vacuo
  6. customafforded a yellow oil which
  7. customsonicated
  8. filtrationThe resulting precipitate was collected by filtration

Quellen und Nachweise

ORD-Eintrag
ord-0d63fcd47efe4e4ea4e052cb46303714
Quelldatensatz
uspto-grants-2009_01
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07476666B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion